QuickView for cGMP-inhibited cyclic-nucleotide phosphodiesterase activity (biogroup)

1. Lung cancer A549 control or NFE2L1 knockout cells treated with bortezomib
2. Cardiosphere derived cells of cardiac ischemia patient with ability to support angiogenesis
3. Prostate cancer PC3 cells with gene overexpression of PROL1
4. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
5. L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations

1. Differential expression of cGMP-inhibited cyclic nucleotide phosphodiesterases in human hepatoma cel…

There were no clinical trials for cGMP-inhibited cyclic-nucleotide phosphodiesterase activity